Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
AHG · against 471 other Healthcare companies of similar size
Ranked #433 of 472 · scores higher than 0% of peers
Bars: peers in each 10-point band of the valuation score152 peers with a valuation score of 0–9, including AHG · Click a bar to see the companies
Mainly because of its earnings yield and EBITDA yield, which are weaker than most Healthcare peers.
| Metric | AHG | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 461 reported | -2.5% | 1.3% | 34% | 30% | |
| EBITDA yieldHigher is better · 478 reported | -0.2% | 4.2% | 32% | 50% | |
| Free cash flow yieldHigher is better · 204 reported | Not reported | -2.5% | — | — | 20% |
| Book yieldHigher is better · 469 reported | 17.4% | 41.4% | 19% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 12.9B HKD (≈$1.7B) | 99 | 83 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 14.8B MXN (≈$800M) | 99 | 61 | |
| 433 | 9.4B CNY (≈$1.3B) | 0 | 28 | |
| 433 | 6.8B CNY (≈$959M) | 0 | 43 | |
| 433 | 7.2B CNY (≈$1.0B) | 0 | 34 | |
| 433 | 14.2B CNY (≈$2.0B) | 0 | 10 | |
| 433 | 1.0B USD | 0 | 35 | |
| 433 | 617M USD | 0 | 28 | |
| 433 | 1.2B USD | 0 | ||
| 433 | 1.2B USD | 0 | 3 | |
| 433 | 1.8B USD | 0 | 30 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score